Biochemical and Functional Study of Antithrombin III in Newborn Infants

Summary

Antithrombin III (AT-III) was isolated by heparin affinity chromatography from adult venous and newborn term and preterm umbilical cord blood. The purified proteins were compared by SDS-PAGE, rocket immuno-electrophoresis, protein concentration by microbiuret relative to optical density at 280 nm, heparin cofactor specific activity, progressive neutralization of thrombin and factor Xa at 37°C and pH related antithrombin kinetics. The structural evaluations revealed a fetal AT-III of molecular weight, charge and electrophoretic migration indistinguishable from adult AT-III. The functional studies showed that, on an equimolar basis, the rates of thrombin and Xa interactions with fetal AT-III were as rapid as those with adult AT-III. The catalytic rates of various concentrations of heparin were also equal. The newborn infant, therefore, displays a quantitative but not qualitative deficiency of AT-III.

Key words

Key words Antithrombin III - Fetal - Adult - Purification - Heparin cofactor activity

• References

• 1 Mokrohisky SE, Levine RL, Blumhagen JD, Wesenberg RL, Simmons MA. Low positioning of umbilical artery catheters increases associated complications in newborn infants. N Engl J Med 1978; 299: 561-564
• 2 Oppenheimer EH, Esterly JR. Thrombosis in the newborn: comparison between infants of diabetic and nondiabetic mothers. J Pediatr 1965; 67: 549-556
• 3 Wesley JR, Keens TG, Miller SW, Platzker ACG. Pulmonary embolism in the neonate: occurrence during a course of total parenteral nutrition. J Pediatr 1978; 93: 113-115
• 4 Barnard DR, Hathaway WE. Neonatal thrombosis. Am J Pediatric Hematol Oncol 1979; 1: 235-244
• 5 Hathaway WE, Neumann LL, Borden CA, Jacobson LJ. Immunologic studies of AT-III heparin cofactor in the newborn. Thromb Haemostas 1978; 39: 624-630
• 6 Stuart MJ. Deficiency of plasma PGI₂-like regenerating activity in neonatal plasma. Reversal by vitamin E in vitro. Pediatr Res 1981; 15: 971-973
• 7 Markarian M, Lubchenco LO, Rosenblat E, Fernandez F, Lang D, Jackson JJ, Bannon AE, Londley A, Githens JH, Martorell R. Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. Biol Neonate 1971; 17: 98-111
• 8 McDonald MM, Jacobson LJ, Hay WE, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981; 15: 1015-1018
• 9 Munkres KD, Richards FM. The purification and properties of neurospora malate dehydrogenase. Arch Biochem Biophys 1965; 109: 466-479
• 10 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45-52
• 11 Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
• 12 Abildgaard U, Lie M, Odegard OR. Antithrombin (heparin cofactor) assay with »new« chromogenic substrates (S-2238 and chromozym TH). Thromb Res 1977; 11: 549-553
• 13 Reeve EB, Leonard B, Wentland SH, Damus P. Studies with ¹³¹J-labelled antithrombin III in dogs. Thromb Res 1980; 20: 375-389
• 14 Griffith MJ, Beaves G, Kingdon HS, Lundblad RL. Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction. Thromb Res 1980; 17: 29-39
• 15 Damus PS, Rosenberg RD. Antithrombin-Heparin Cofactor. In Lorand L. (ed.) Methods in Enzymology XLV; Proteolytic Enzymes B. 653-669 Academic Press; New York: 1976
• 16 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 17 Mahasandana C, Hathaway WE. Circulating anticoagulants in the newborn: relation to hypercoagulability and the idiopathic respiratory distress syndrome. Pediatr Res 1973; 7: 670-673
• 18 Reeve EB. Steady state relations between factors X, Xa, II, IIa, AT-III and α₂ M in thrombosis. Thromb Res 1980; 18: 19-31
• 19 Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13: 1330-1335